Clinical Trials Directory

Trials / Completed

CompletedNCT06389955

Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654

A Phase 1, Randomized, Study in Healthy Volunteers to Assess Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Sumitomo Pharma America, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study comprised of 2 parts, Part A and Part B. Part B will only be conducted if the relative bioavailability of the tablet formulation was at least 70% of the capsule formulation.

Detailed description

Part A is a randomized, single-dose, 4-period, 4-way cross-over study to evaluate the effect of food on the TP 3654 capsule and assess the relative bioavailability of the TP-3654 capsule versus tablet formulations. Following a screening period of up to 28 days, eligible participants will be admitted to the clinical research unit (CRU) on Day -1. Participants will fast overnight from Day -1 to Day 1. On Day 1, participants will be randomly assigned to a treatment sequence, and they will receive TP-3654 per their assigned sequence. Part B is a randomized, single-dose, 3-period, 3-way cross-over study to evaluate the effect of food on the PK of the TP-3654 tablet formulation. Following a screening period of up to 28 days, eligible participants will be admitted to the CRU on Day -1. As with Part A, participants will fast overnight from Day -1 to Day 1. On Day 1, they will be randomly assigned to a treatment sequence, and they will receive TP-3654 per their assigned sequence.

Conditions

Interventions

TypeNameDescription
DRUGTP 3654TP 3654 is an investigational orally delivered drug

Timeline

Start date
2023-05-22
Primary completion
2023-08-01
Completion
2023-08-24
First posted
2024-04-29
Last updated
2024-09-19

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06389955. Inclusion in this directory is not an endorsement.